Yingdong M. Li

35 Dingxi East Road
Lanzhou, 730000, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 46 publications

Efficacy and safety of combining commercial Chinese polyherbal preparation with conventional medicine in the treatment of coronary microvascular disease: a systematic review and network meta-analysis.

Efficacy and safety of combining commercial Chinese polyherbal preparation with conventional medicine in the treatment of coronary microvascular disease: a systematic review and network meta-analysis.

Journal: Frontiers in pharmacology

Published: April 03, 2026

Type one protein phosphatases (TOPPs) catalyze EIN2 dephosphorylation to regulate ethylene signaling in Arabidopsis.

Type one protein phosphatases (TOPPs) catalyze EIN2 dephosphorylation to regulate ethylene signaling in Arabidopsis.

Journal: Science advances

Published: February 11, 2026

Formononetin, an active component of RAS-RH, ameliorates radiation-induced mitochondrial fission dysfunction in endothelial cells via TCs-ECs crosstalk.

Formononetin, an active component of RAS-RH, ameliorates radiation-induced mitochondrial fission dysfunction in endothelial cells via TCs-ECs crosstalk.

Journal: Microvascular research

Published: December 19, 2025

Chrysin: Phytochemistry, Pharmacology, Pharmacokinetics, Nano-Delivery Strategy, and Derivative Innovation.

Chrysin: Phytochemistry, Pharmacology, Pharmacokinetics, Nano-Delivery Strategy, and Derivative Innovation.

Journal: The American journal of Chinese medicine

Published: December 09, 2025

Research progress of bioactive compounds of Traditional Chinese medicine in the treatment of myocardial fibrosis-related signaling pathways.

Research progress of bioactive compounds of Traditional Chinese medicine in the treatment of myocardial fibrosis-related signaling pathways.

Journal: Journal of ethnopharmacology

Published: August 10, 2025

Targeting inhibition of the inflammatory response: advances in the treatment of myocardial fibrosis with natural medicine and active ingredients.

Targeting inhibition of the inflammatory response: advances in the treatment of myocardial fibrosis with natural medicine and active ingredients.

Journal: Frontiers in cardiovascular medicine

Published: May 12, 2025

RAS-RH up-regulates the level of miR-126 and inhibits the opening of mPTP in a rat model of coronary microvascular disease.

RAS-RH up-regulates the level of miR-126 and inhibits the opening of mPTP in a rat model of coronary microvascular disease.

Journal: Microvascular research

Published: April 27, 2025

Myocardial fibrosis and glycolysis: a bibliometric study and visualization analysis (2000-2024).

Myocardial fibrosis and glycolysis: a bibliometric study and visualization analysis (2000-2024).

Journal: Journal of translational medicine

Published: March 28, 2025

Salvia miltiorrhiza Bunge root in the treatment of myocardial fibrosis: research progress and challenges.

Salvia miltiorrhiza Bunge root in the treatment of myocardial fibrosis: research progress and challenges.

Journal: Frontiers in pharmacology

Published: January 16, 2025

Elucidating the preventive and therapeutic effects of cardiac telocytes paracrine microRNAs on ischemic heart disease.

Elucidating the preventive and therapeutic effects of cardiac telocytes paracrine microRNAs on ischemic heart disease.

Journal: Frontiers in cardiovascular medicine

Published: December 17, 2024

Hypertension-gut microbiota research trends: a bibliometric and visualization analysis (2000-2025).

Hypertension-gut microbiota research trends: a bibliometric and visualization analysis (2000-2025).

Journal: Frontiers in microbiology

Published: December 11, 2024

Role of circadian transcription factor REV-ERB in cardiovascular diseases: a review.

Role of circadian transcription factor REV-ERB in cardiovascular diseases: a review.

Journal: Frontiers in cardiovascular medicine

Published: October 24, 2024

Showing 1-12 of 46

Last Updated: 09/26/2026